Regis Industries Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
as on 06-07-2024
- Paid Up Capital ₹ 17.21 Cr
as on 06-07-2024
- Company Age 42 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
About Regis Industries
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 543208.
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 20.00 Cr and a paid-up capital of Rs 17.21 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Regis Industries Limited India are Chandrakant Parmar as CFO and Kinjal Dalal as Company Secretary. Chhayaben Parmar, Komalben Chauhan, and Chandrakant Parmar serve as directors at the Company.
- CIN/LLPIN
L51109WB1982PLC034759
- Company No.
034759
- Stock Symbol
BSE : 543208
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
05 Apr 1982
- Date of AGM
26 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Listed
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Regis Industries?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Chandrakant Parmar | CFO | 22-Nov-2021 | Current |
Kinjal Dalal  | Company Secretary | 16-Aug-2018 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Chhayaben Parmar | Additional Director | 10-Jan-2024 | Current |
| Komalben Chauhan | Director | 04-Aug-2022 | Current |
Financial Performance and Corporate Structure Insights of Regis Industries.
Regis Industries Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Regis Industries?
In 2022, Regis Industries had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Biogen Pharmachem Industries LimitedActive 29 years 5 monthsChhayaben Parmar, Komalben Chauhan and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Regis Industries?
Unlock and access historical data on people associated with Regis Industries, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Regis Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Regis Industries's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
